JP2015533798A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015533798A5 JP2015533798A5 JP2015531325A JP2015531325A JP2015533798A5 JP 2015533798 A5 JP2015533798 A5 JP 2015533798A5 JP 2015531325 A JP2015531325 A JP 2015531325A JP 2015531325 A JP2015531325 A JP 2015531325A JP 2015533798 A5 JP2015533798 A5 JP 2015533798A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- polypeptide
- wound
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261699160P | 2012-09-10 | 2012-09-10 | |
| US61/699,160 | 2012-09-10 | ||
| US13/829,876 | 2013-03-14 | ||
| US13/829,876 US20140072613A1 (en) | 2012-09-10 | 2013-03-14 | Compositions and Methods for Treating Cutaneous Scarring |
| PCT/US2013/059060 WO2014040074A2 (en) | 2012-09-10 | 2013-09-10 | Compositions and methods for treating cutaneous scarring |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015533798A JP2015533798A (ja) | 2015-11-26 |
| JP2015533798A5 true JP2015533798A5 (enExample) | 2016-04-07 |
| JP6247692B2 JP6247692B2 (ja) | 2017-12-13 |
Family
ID=50233502
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015531325A Expired - Fee Related JP6247692B2 (ja) | 2012-09-10 | 2013-09-10 | 皮膚瘢痕を治療する組成物及び方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20140072613A1 (enExample) |
| EP (1) | EP2892546A4 (enExample) |
| JP (1) | JP6247692B2 (enExample) |
| KR (1) | KR102040710B1 (enExample) |
| CN (1) | CN105120886A (enExample) |
| AU (1) | AU2013312120B2 (enExample) |
| CA (1) | CA2884264A1 (enExample) |
| GB (1) | GB2520897B (enExample) |
| HK (2) | HK1210422A1 (enExample) |
| MX (1) | MX368878B (enExample) |
| NZ (1) | NZ705743A (enExample) |
| RU (2) | RU2705211C2 (enExample) |
| SG (1) | SG11201501818VA (enExample) |
| WO (1) | WO2014040074A2 (enExample) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3643782A1 (en) | 2008-02-11 | 2020-04-29 | Phio Pharmaceuticals Corp. | Modified rnai polynucleotides and uses thereof |
| EP2342340A1 (en) | 2008-09-22 | 2011-07-13 | Rxi Pharmaceuticals Corporation | Rna interference in skin indications |
| US9074211B2 (en) | 2008-11-19 | 2015-07-07 | Rxi Pharmaceuticals Corporation | Inhibition of MAP4K4 through RNAI |
| WO2010090762A1 (en) | 2009-02-04 | 2010-08-12 | Rxi Pharmaceuticals Corporation | Rna duplexes with single stranded phosphorothioate nucleotide regions for additional functionality |
| US9095504B2 (en) | 2010-03-24 | 2015-08-04 | Rxi Pharmaceuticals Corporation | RNA interference in ocular indications |
| WO2011119852A1 (en) | 2010-03-24 | 2011-09-29 | Rxi Pharmaceuticals Corporation | Reduced size self-delivering rnai compounds |
| CA2794189C (en) | 2010-03-24 | 2022-01-11 | Rxi Pharmaceuticals Corporation | Rna interference in dermal and fibrotic indications |
| EP2943564B1 (en) | 2013-01-09 | 2026-03-25 | International Stem Cell Corporation | Sl327 for use in skin regeneration |
| JP6772062B2 (ja) * | 2013-12-02 | 2020-10-21 | フィオ ファーマシューティカルズ コーポレーションＰｈｉｏ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｃｏｒｐ． | 癌の免疫療法 |
| EP3188799B1 (en) | 2014-09-05 | 2022-07-06 | Phio Pharmaceuticals Corp. | Methods for treating aging and skin disorders using nucleic acids targeting tyr or mmp1 |
| KR20170102900A (ko) | 2015-01-08 | 2017-09-12 | 모레 매트릭스 인코포레이티드 | Mk2 저해제 펩타이드의 제형 |
| CA2978941A1 (en) | 2015-03-12 | 2016-09-15 | Moerae Matrix, Inc. | Use of mk2 inhibitor peptide-containing compositions for treating non-small cell lung cancer with same |
| CN104689301A (zh) * | 2015-03-27 | 2015-06-10 | 吴开刚 | 一种祛除妊娠纹的药物及其制备方法 |
| US10709702B2 (en) | 2015-10-08 | 2020-07-14 | Amd Therapeutics Llc | Treatment of skin disorders by topical administration of VEGF inhibitors |
| CN105709270B (zh) * | 2016-03-18 | 2019-01-01 | 中国科学院长春应用化学研究所 | 一种用于干细胞治疗的水凝胶敷料 |
| JP6815782B2 (ja) * | 2016-07-29 | 2021-01-20 | 小林製薬株式会社 | α−ＳＭＡ産生抑制剤 |
| EP3532071A4 (en) * | 2016-10-30 | 2020-09-02 | Sirnaomics, Inc. | PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE TO ACTIVATE HUMAN FIBROBLAST AND MYOFIBROBLAST APOPTOSIS |
| KR101921727B1 (ko) * | 2016-12-28 | 2018-11-23 | 주식회사 제네웰 | 실리콘 수지 조성물, 이의 제조방법 및 이를 포함하는 흉터 치료제 |
| JP7167059B2 (ja) | 2017-04-19 | 2022-11-08 | フィオ ファーマシューティカルズ コーポレーション | 核酸化合物の局所送達 |
| EP3675874B1 (en) * | 2017-09-01 | 2023-11-29 | Excel Med, LLC | Pharmaceuticals composition for treating keloid and uses thereof |
| US10485755B1 (en) * | 2018-02-05 | 2019-11-26 | Wade Cheng | Formulation and method for treatment of non-acne scars |
| EP3749750A1 (en) * | 2018-02-09 | 2020-12-16 | Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH | Means and methods for monitoring scar development |
| CN108451981B (zh) * | 2018-04-21 | 2019-07-23 | 江西汉氏联合干细胞科技有限公司 | 使用皮肤间充质干细胞治疗系统性硬化症 |
| WO2019222520A1 (en) * | 2018-05-16 | 2019-11-21 | The Board Of Trustees Of The Leland Stanford Junior University | Controlled hydrogel delivery of focal adhesion kinase inhibitor for decreased scar formation |
| CN111558128A (zh) * | 2019-03-26 | 2020-08-21 | 华中科技大学同济医学院附属协和医院 | 一种载瘢痕修复药物的可溶性微针阵列及制备方法 |
| US20220202827A1 (en) * | 2019-04-08 | 2022-06-30 | The General Hospital Corporation | Enhancement of Melanocyte Migration Using ROCK Inhibitors |
| US11904000B2 (en) | 2019-05-06 | 2024-02-20 | Brown University | Compositions and methods to enhance cutaneous wound healing |
| WO2020227738A1 (en) * | 2019-05-09 | 2020-11-12 | The University Of Chicago | Novel material for skin wound closure and scar prevention |
| US20210000910A1 (en) | 2019-07-03 | 2021-01-07 | Jysk Skin Solutions Pte Ltd | Topical compositions |
| RU2712183C1 (ru) * | 2019-09-30 | 2020-01-24 | Государственное бюджетное учреждение здравоохранения Московской области "Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского" (ГБУЗ МО МОНИКИ им. М.Ф. Владимирского) | Способ лечения пациентов с рубцовыми поражениями кожи |
| CN110917179B (zh) * | 2019-12-19 | 2021-04-27 | 温州医科大学附属第一医院 | 一种抗疤痕硅凝胶贴及其制备方法 |
| WO2021145699A1 (ko) * | 2020-01-17 | 2021-07-22 | 한국생명공학연구원 | 콜히친을 포함하는 피부 질환 치료용 조성물 |
| US12360428B2 (en) * | 2020-04-13 | 2025-07-15 | Massachusetts Institute Of Technology | Melanin-peptide-based photonic materials |
| CN112425560A (zh) * | 2020-10-27 | 2021-03-02 | 纳肽得有限公司 | 皮肤增生性瘢痕动物模型及其构建方法 |
| CN113143524A (zh) * | 2021-04-13 | 2021-07-23 | 王伟 | 一种用于构建微创兔膝关节炎模型的穿刺系统 |
| US20240226233A1 (en) * | 2021-05-03 | 2024-07-11 | L&C Bio Co., Ltd. | Composition comprising zag-derived peptide for improving scars and keloids |
| CA3220398A1 (en) * | 2021-07-30 | 2023-02-02 | Geoffrey Gurtner | Mechanotransduction disruption mediation in skin grafting methods and compositions for use in practicing the same |
| EP4464694A4 (en) | 2022-01-14 | 2026-04-01 | Shanghai Hansoh Biomedical Co Ltd | POLYCYCLIC DERIVATIVE CONTAINING PYRIDINE, ITS PREPARATION PROCESS AND ITS USE |
| US12083204B2 (en) | 2022-06-02 | 2024-09-10 | L'oreal | Topical composition for homeostatic delivery of nitric oxide and uses thereof |
| KR102696817B1 (ko) * | 2023-07-06 | 2024-08-21 | 주식회사 아루다 | 히알루론산, 프로테오글리칸, 글리코사미노글리칸, 아텔로콜라겐, 베타글루칸, 유비퀴논 및 비타민 e를 포함하는 에스테틱 조성물 및 이의 제조 방법 |
| CN117304303B (zh) * | 2023-07-14 | 2024-07-05 | 杭州恩和生物科技有限公司 | 纤连蛋白截短片段、组合物及用途 |
| WO2026076246A1 (en) * | 2024-10-03 | 2026-04-09 | Frontier Bio Corporation | Methods and systems for generating vascularized neurospheres |
| KR20260090760A (ko) * | 2024-12-09 | 2026-06-17 | 온바이오 주식회사 | 봉합자국 및 흉터를 최소화 할 수 있는 재건 미용 시술방법 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2200557C1 (ru) * | 2001-11-23 | 2003-03-20 | Государственное учреждение Межотраслевой научно-технический комплекс "Микрохирургия глаза" им. акад. С.Н.Федорова | Способ лечения гипертрофических и келоидных рубцов |
| ES2594281T3 (es) | 2007-01-10 | 2016-12-19 | Purdue Research Foundation | Inhibidores polipeptídicos de HSP27 quinasa y usos de los mismos |
| US20080293640A1 (en) * | 2007-01-10 | 2008-11-27 | Arizona Board of Regents, A body Corporate, of the State of Arizona, acting for and on behalf of | Polypeptide inhibitors of HSP27 kinase and uses therefor |
| WO2008109794A2 (en) | 2007-03-08 | 2008-09-12 | Tufts Medical Center | The role of the mk2 pathway in treating fibrosis and scarring |
| DK2185698T3 (en) * | 2007-08-07 | 2015-07-27 | Purdue Research Foundation | Kinase Inhibitors and Uses thereof |
| WO2009038783A1 (en) * | 2007-09-19 | 2009-03-26 | Surmodics, Inc. | Biocompatible foams, systems, and methods |
| EP2252690A2 (en) * | 2007-12-21 | 2010-11-24 | Coda Therapeutics, Inc. | Use of anti-connexin 43 polynucleotides for the treatment of abnormal or excessive scars |
| CN102256613B (zh) * | 2008-10-20 | 2014-09-10 | 莫伊莱麦屈克斯公司 | 用于治疗或者预防粘连的多肽 |
| US9327008B2 (en) | 2008-12-10 | 2016-05-03 | Purdue Research Foundation | Cell-permeant peptide-based inhibitor of kinases |
| WO2010098760A1 (en) * | 2009-02-26 | 2010-09-02 | Hewlett-Packard Development Company, L.P. | Void pantographs and methods for generating the same |
| US9890195B2 (en) | 2009-07-27 | 2018-02-13 | Purdue Research Foundation | MK2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration |
| WO2011160055A2 (en) * | 2010-06-18 | 2011-12-22 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Hair follicle neogenesis |
| WO2012082950A2 (en) * | 2010-12-14 | 2012-06-21 | University Of Rochester | Chimeric fibronectin matrix mimetics and uses thereof |
| DK2670411T3 (da) | 2011-02-02 | 2019-05-13 | Excaliard Pharmaceuticals Inc | Antisense-forbindelser rettet mod bindevævsvækstfaktor (CTGF) til anvendelse i en fremgangsmåde til behandling af keloider eller hypertrofiske ar |
-
2013
- 2013-03-14 US US13/829,876 patent/US20140072613A1/en not_active Abandoned
- 2013-09-10 JP JP2015531325A patent/JP6247692B2/ja not_active Expired - Fee Related
- 2013-09-10 RU RU2015113011A patent/RU2705211C2/ru not_active IP Right Cessation
- 2013-09-10 KR KR1020157009219A patent/KR102040710B1/ko not_active Expired - Fee Related
- 2013-09-10 WO PCT/US2013/059060 patent/WO2014040074A2/en not_active Ceased
- 2013-09-10 HK HK15111211.3A patent/HK1210422A1/xx unknown
- 2013-09-10 AU AU2013312120A patent/AU2013312120B2/en not_active Ceased
- 2013-09-10 RU RU2019126644A patent/RU2019126644A/ru unknown
- 2013-09-10 CA CA2884264A patent/CA2884264A1/en not_active Abandoned
- 2013-09-10 GB GB1505972.8A patent/GB2520897B/en not_active Expired - Fee Related
- 2013-09-10 SG SG11201501818VA patent/SG11201501818VA/en unknown
- 2013-09-10 CN CN201380058533.9A patent/CN105120886A/zh active Pending
- 2013-09-10 MX MX2015003075A patent/MX368878B/es active IP Right Grant
- 2013-09-10 NZ NZ705743A patent/NZ705743A/en not_active IP Right Cessation
- 2013-09-10 EP EP13834451.0A patent/EP2892546A4/en not_active Withdrawn
- 2013-09-10 HK HK15111150.6A patent/HK1210414A1/xx unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2015113011A (ru) | Композиции и способы лечения кожных рубцов | |
| Su et al. | Enhancement of skin wound healing with decellularized scaffolds loaded with hyaluronic acid and epidermal growth factor | |
| Kakudo et al. | Platelet-rich plasma promotes epithelialization and angiogenesis in a splitthickness skin graft donor site | |
| EP3395383B1 (en) | Cell preparations for extemporaneous use, useful for healing and rejuvenation in vivo | |
| US20100239556A1 (en) | Promoting ecm production by fibroblast cells and/or promoting migration of fibroblast cells in a biological system | |
| Wang et al. | Polyurethane membrane/knitted mesh-reinforced collagen–chitosan bilayer dermal substitute for the repair of full-thickness skin defects via a two-step procedure | |
| JP6639587B2 (ja) | 損傷組織の再生 | |
| CN102781463A (zh) | 用于皮肤再生的方法和组合物 | |
| Park et al. | Collagen/poly (D, L-lactic-co-glycolic acid) composite fibrous scaffold prepared by independent nozzle control multi-electrospinning apparatus for dura repair | |
| WO2020086812A1 (en) | Functional wound healing dressings | |
| JP2016121158A (ja) | 創傷の治癒 | |
| US20240293596A1 (en) | Compositions and methods for treating wounds | |
| Jones et al. | Effect of topical recombinant TGF-β on healing of partial thickness injuries | |
| WO2013065017A2 (en) | Platelet rich plasma (prp) and prominin-1 derived peptide stimulate lymphangiogenesis | |
| CN113194965B (zh) | 用于治疗伤口的药物组合物 | |
| Conway et al. | Wound healing in the diabetic foot | |
| Mahanani et al. | Effect of Incorporation Platelet Rich Plasma into Synthetic Coral Scaffold toward Epithelial Thickness of Wound Healing | |
| Giatsidis et al. | Dermal Regeneration and Induction of Wound Closure in Diabetic Wounds | |
| JP4578067B2 (ja) | 局所医薬組成物 | |
| Berry-Kilgour | Biomaterial-Based Delivery of a Growth Factor and Cytokine Combination to Address Wound Healing Complications | |
| 최진일 | Assessment of Wound Healing Efficacy of Porcine Placental Amniotic Membrane Derived Extracellular Matrix | |
| WO2003049782A1 (en) | Von willebrand factor-coated biocompatible implants | |
| Hrynyk | Enhanced burn wound healing through controlled and sustained delivery of bioactive insulin from alginate sponge dressings | |
| Lorenz et al. | Wounds: Biology | |
| Mandal | Anti-inflammatory effect of epidermal growth factor conjugated silk fibroin immobilized polyurethane ameliorates diabetic burn wound healing Sohini Sena±, Piyali Basaka±, Bishnu Prasad Sinhab, Praveen Mauryec, Krishna Kumar Jaiswald, Partho Dase, Tapan Kumar Mandalb aSchool of Bioscience & Engineering, Jadavpur University |